ADAM MYERS: Open Payments
NPI 1407219587 · MURRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 24 payments from 18 companies in 2025. Trend: 2023 $362 · 2024 $751 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $51 |
| ABBVIE INC. | 2 | $40 |
| Amgen Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $30 |
| Stryker Corporation | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Novo Nordisk Inc | 2 | $28 |
| Boston Scientific Corporation | 1 | $25 |
| Baxter Healthcare | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: Veozah, UBRELVY, OTEZLA, CLOTTRIEVER BOLD CATHETER, VOQUEZNA, Ozempic, BodyGuardian, Hillrom - Vest System Model 105 Home Care.
Industry payments across KY — which companies pay providers there.
